We detected data shifts using our monitoring pipeline (Figure 2A)48 across varying sample sizes for deployment threats including the COVID-19 pandemic, differences between hospital types, and changes in laboratory assays (specifically troponin, D-dimer, and BNP) (Table). The gene discussed is NPPB; the disease is COVID-19.